(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
申请人:Atwal Karnail S.
公开号:US06916813B2
公开(公告)日:2005-07-12
Compounds having the formula (I), and pharmaceutically acceptable salts thereof,
are useful for modulating mitochondrial F
1
F
0
ATPase activity and treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias.
具有式(I)的化合物及其药学上可接受的盐,对于调节线粒体F1F0ATP酶活性和治疗缺血性疾病,包括心肌梗死、充血性心力衰竭和心律失常,具有用途。